Archive for the ‘Uncategorized’ Category
Why did you access ViroBlogy today?
25 July, 2016Protection of Cattle against Rinderpest by Vaccination with Wild-Type Peste des Petits Ruminants Virus
30 April, 2016Although rinderpest virus (RPV) has been eradicated in the wild, efforts are still continuing to restrict the extent to which live virus is distributed in facilities around the world and to prepare for any reappearance of the disease, whether through deliberate or accidental release. In an effort to find an alternative vaccine which could be used in place of the traditional live attenuated RPV strains, we have determined whether cattle can be protected from rinderpest by inoculation with vaccine strains of the related morbillivirus, peste des petits ruminants virus (PPRV). Cattle were vaccinated with wild-type PPRV or either of two established PPRV vaccine strains, Nigeria/75/1 or Sungri/96. All animals developed antibody and T cell immune responses to the inoculated PPRV. However, only the animals given wild-type PPRV were protected from RPV challenge. Animals given PPRV/Sungri/96 were only partially protected, and animals given PPRV/Nigeria/75/1 showed no protection against RPV challenge. While sera from animals vaccinated with the vaccine strain of RPV showed cross-neutralizing ability against PPRV, none of the sera from animals vaccinated with any strain of PPRV was able to neutralize RPV although sera from animals inoculated with wild-type PPRV were able to neutralize RPV-pseudotyped vesicular stomatitis virus.
Sourced through Scoop.it from: jvi.asm.org
See on Scoop.it – Virology News
Dengue Virus Antibodies Enhance Zika Virus Infection
26 April, 2016We tested the neutralizing and enhancing potential of well-characterized broadly neutralizing human anti-DENV monoclonal antibodies (HMAbs) and human DENV immune sera against ZIKV using neutralization and ADE assays. We show that anti-DENV HMAbs, cross-react, do not neutralize, and greatly enhance ZIKV infection in vitro. DENV immune sera had varying degrees of neutralization against ZIKV and similarly enhanced ZIKV infection.
Conclusions / Significance
Our results suggest that pre-existing DENV immunity will enhance ZIKV infection in vivo and may increase disease severity. A clear understanding of the interplay between ZIKV and DENV will be critical in informing public health responses in regions where these viruses co-circulate and will be particularly valuable for ZIKV and DENV vaccine design and implementation strategies.
Zika virus graphic from Russell Kightley Media
Sourced through Scoop.it from: biorxiv.org
See on Scoop.it – Virology News
New Zika Mouse Model Mimics Human Disease
6 April, 2016Researchers develop another mouse model of Zika virus infection that mimics the disease in humans.
Sourced through Scoop.it from: www.the-scientist.com
“Minimal cell raises stakes in race to harness synthetic life”. Really??
29 March, 2016Genomics entrepreneur Craig Venter has created a synthetic cell that contains the smallest genome of any known, independent organism. Functioning with 473 genes, the cell is a milestone in his team’s 20-year quest to reduce life to its bare essentials and, by extension, to design life from scratch.
Venter, who has co-founded a company that seeks to harness synthetic cells for making industrial products, says that the feat heralds the creation of customized cells to make drugs, fuels and other products. But an explosion in powerful ‘gene-editing’ techniques, which enable relatively easy and selective tinkering with genomes, raises a niggling question: why go to the trouble of making new life when you can simply tweak what already exists?
Thomas Deerinck and Mark Ellisman/NCMIR/UCSD
Each cell of JCVI-syn3.0 contains just 473 genes, fewer than any other independent organism.
Unlike the first synthetic cells made in 20101, in which Venter’s team at the J. Craig Venter Institute in La Jolla, California, copied an existing bacterial genome and transplanted it into another cell, the genome of the minimal cells is like nothing in nature. Venter says that the cell, which is described in a paper released on 24 March in Science2, constitutes a brand new, artificial species.
Sourced through Scoop.it from: www.nature.com
See on Scoop.it – Virology News
Was I wrong on HIV/AIDS: Thabo Mbeki. Answer: yes. Yes, you were.
7 March, 2016In 2002 a few of us here in South Africa wrote a booklet entitled “Castro Hlongwane…”‚ and sub-titled it “HIV/AIDS and the Struggle for the Humanisation of the African”.
AN OVERVIEW
Here is an excerpt from that booklet, which speaks for itself: “The first report on the incidence of HIV in South and Southern Africa was published in the “New England Journal of Medicine” and the “South African Medical Journal”, both in 1985. Two of the most important findings in this report were that in our country and region:
HIV infection was confined to male homosexuals; and,
HIV was not endemic in this region of the world.
To quote this report, it said: “The only positive subjects were in the group compromising male homosexuals. The majority of these positive subjects had either recently been to the United States or had had sexual contact with other homosexuals who had visited the United States…
Sourced through Scoop.it from: www.timeslive.co.za
See on Scoop.it – Virology News
How Mbeki’s character and his AIDS denialism are intimately linked
3 March, 2016Critics say that Thabo Mbeki’s character matters less than his AIDS denialism. But these things are actually intimately linked.
Sourced through Scoop.it from: theconversation.com
See on Scoop.it – Virology News
‘Alien DNA’ raining down on Earth could mix with Zika and form super disease – NOT!
2 March, 2016“Scientists have warned that panspermia – the theory of genetic material raining down from space – could make Zika stronger and more deadly”
Genetic material falling on Earth from outer space could create a supercharged version of the Zika virus, scientists have warned.
Experts claim that the virus, which is spreading across the globe, will become more prevalent and deadly in the future.
Changes in Zika have already been noted, as it’s changed to be passable through sexual contact.
The disease, first discovered in monkeys in 1947, had previously only been transferable by mosquito bite.
But now, scientists are warning that it could mutate, growing stronger and spreading more easily – with its victims suffering more serious consequences.
They have warned that future strains could become worse thanks to panspermia – the theory of genetic material constantly raining down on Earth from outer space.
Sourced through Scoop.it from: www.mirror.co.uk
See on Scoop.it – Virology News
Structural and molecular basis for Ebola virus neutralization by protective human antibodies
27 February, 2016Ebola virus causes hemorrhagic fever with a high mortality rate and for which there is no approved therapy. Two human monoclonal antibodies, mAb100 and mAb114, in combination, protect nonhuman primates against all signs of Ebola virus disease, including viremia. Here, we demonstrate that mAb100 recognizes the base of the Ebola virus glycoprotein (GP) trimer, occludes access to the cathepsin-cleavage loop, and prevents the proteolytic cleavage of GP that is required for virus entry. We show that mAb114 interacts with the glycan cap and inner chalice of GP, remains associated following proteolytic removal of the glycan cap, and inhibits binding of cleaved GP to its receptor. These results define the basis of neutralization for two protective antibodies and may facilitate development of therapies and vaccines.
Sourced through Scoop.it from: science.sciencemag.org
Why is it that structural / molecular immunologic studies always "may facilitate development of therapies and vaccines"? Really?? How about looking at what the actual vaccines did in terms of eliciting sterilising immunity, or controlling viral load?
So nice work, but it characterises the mode of action of just two monoclonal antibodies from the spectrum of many thousand that would be involved in reaction to infection, and of the hundreds that are involved in vaccine responses, and the many in any single individual that would be involved in actual neutralisation of infectivity / ADCC / infected cell killing, etc.
What I’m getting at is that whole protein responses, in the context of live vaccine vector inoculations, are almost certainly more complex than anything that involves just these two antibodies, and elegant immunological / structural studies are a minor part of understanding the whole problem.
See on Scoop.it – Virology News
GM viruses could help prevent animal diseases jumping to humans
23 February, 2016Vaccinating wildlife with genetically-modified viruses could one day help stop diseases like Ebola and MERS jumping from animals to humans, researchers say.
Sourced through Scoop.it from: www.abc.net.au
In principle, a great idea – BUT, as was pointed out, using live viruses in an effectively uncontrolled manner COULD result in all sort of unforeseen outcomes.
Like making a killer virus that drastically reduces numbers of a given species, like myxomatosis and RHDV did to rabbits [OK, they were supposed to].
Like making a virus that spreads to NON-target animals, and does…what? Start a zombie plague? Mutate to virulence, and cause havoc?
The point is, WE DON’T KNOW what may happen – and in circumstances like that, it may be safer to leave well alone!
See on Scoop.it – Virology News







